AXA AFFIN Life Insurance Berhad is introducing a complimentary 2019-nCoV Hospital Assistance Program in response to the rising threat of COVID-19. The Hospital Assistance Program features three key benefits – “Urgent Self-Assistance”, “Family Assistance” and “Hospitalization Waiver Assistance”.
Policyholders will be eligible for a one-time cash payment upfront via notification under “Urgent Self-Assistance” (up to 14 days of hospitalization income benefit*) and an additional one-time cash assistance of RM3,000 to the immediate family under “Family Assistance” – should they be diagnosed with COVID-19 by or before 30 June, 2020.
Should the policyholder be isolated for COVID-19 infection while travelling to the stated provinces of China (Hubei, Zhejiang and Jiangsu) during the cover period, a maximum of RM10,000 lump sum will be paid out under this section.
“Hospitalization Waiver Assistance” offers various policy waivers that will facilitate necessary care for the policyholders upon diagnosis. These assistance include ICU Daily Limits (up to full annual limits of the policy), Consultation and Treatment Costs while in hospital isolation and Intensive Care Unit (full medical expenses as charged), Unlimited Doctor Consultation Day Visits and Unlimited Ambulance Transfer Assistance.
“The outbreak of COVID-19 is a significant threat globally. The health and well-being of our customers and staff remains our top priority. We are here for them during this trying time and we will offer every support to protect our customers and people against this threat”, said Rohit Nambiar, Chief Executive Officer of AXA AFFIN Life Insurance Berhad.
A dedicated 2019-nCoV Assistance Hotline (1300-80-0020) is also made available to provide 24 hours assistance.
The 2019-nCoV Hospital Assistance Program is extended to all medical policies issued with a Hospitalization Income Benefit Rider (HIB) from 1 February, 2020 – 31 March, 2020. All existing medical policies without HIB will only be entitled for “Hospitalization Waiver Assistance”. The cover period for this program is up till 30 June 2020 and might be extended appropriately based on the development of COVID-19 in Malaysia.